A phase II, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinomaAmir A. Jazaeri, Robert M. Wenham, Igor Gorbatchevsky et al.|Gynecologic Oncology|2018Cited by 6
A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma.Amir A. Jazaeri, Emese Zsíros, Robert P. Edwards et al.|Journal of Clinical Oncology|2018Cited by 4